Streetbeat News

Earnings

NERV

Minerva Neurosciences (NASDAQ:NERV) reported a Q4 EPS loss of $1.19, missing the consensus estimate of $0.88 by 35.23%. This represents a slight improvement over the previous year's loss of $1.26 per share. The company also reported having approximately $41M in cash, cash equivalents, and restricted cash.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:24 pm

BHRB

BX

NWE

Insiders have made notable purchases in shares of Blackstone Inc. (BX), NorthWestern Energy Group, Inc. (NWE), and Burke & Herbert Financial Services Corp. (BHRB). These purchases indicate insider confidence in the companies' prospects. Blackstone's insider bought shares at an average price of $125.63, NorthWestern's at $48.80, and Burke & Herbert's at $55.35. Blackstone reported mixed Q4 results, NorthWestern posted upbeat earnings, and Burke & Herbert announced Q4 results and a dividend.

Portfolio Pulse from Avi Kapoor

February 22, 2024 | 12:24 pm

NVDA

QQQ

SPY

Nvidia's impressive earnings report has sparked optimism in the market, leading to a jump in Nasdaq and S&P 500 futures. Investors are now focused on upcoming economic data, including jobless claims and Fed speeches, to gauge the market's direction. Other stocks mentioned include Five9, Lucid Group, Rivian Automotive, Sunnova Energy, and Sunrun, which moved on their earnings reports. Additionally, several companies are set to report their quarterly results.

Portfolio Pulse from Shanthi Rexaline

February 22, 2024 | 12:23 pm

UPBD

Upbound Group (NASDAQ:UPBD) reported Q4 adjusted EPS of $0.81, surpassing the $0.77 estimate, and sales of $1.02B, exceeding the $994.07M estimate. This represents a 5.81% decrease in EPS and a 2.78% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:22 pm

CCCC

C4 Therapeutics (NASDAQ:CCCC) reported a decrease in FY EPS to $(2.67) from $(2.62) YoY and a 33.25% drop in sales to $20.76M from $31.10M YoY.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:19 pm

LAUR

Laureate Education (NASDAQ:LAUR) reported Q4 2023 earnings of $0.26 per share with sales of $409.40M, surpassing the $388.00M estimate. This represents an 18.22% increase over the previous year's sales of $346.30M.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:17 pm

BRC

Brady Corporation has increased the lower end of its fiscal year 2024 adjusted earnings per share (EPS) guidance, revising its outlook from $3.85-$4.10 to $3.95-$4.10, against an estimated $4.07.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:17 pm

BHC

Bausch Health Companies projects its 2024 revenues to be between $9.3B and $9.55B, surpassing the consensus estimate of $8.97B. The company also forecasts its adjusted EBITDA to range from $3.20B to $3.35B.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:15 pm

NABL

N-able has updated its Q1 2024 financial outlook, expecting revenue between $111M-$111.5M, surpassing the $110.975M estimate, and adjusted EBITDA between $37.5M-$38M. This reflects an 11%-12% year-over-year growth and EBITDA representing about 34% of total revenue.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:14 pm

NABL

N-able projects FY24 revenue to be between $460M and $465M, slightly below the $465.39M estimate, with adjusted EBITDA expected to be between $158M and $162M, indicating a 9% to 11% year-over-year growth on a constant currency basis.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:13 pm